🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

18,54 USD

Máx. histórico

178,74

2142 días

Split 1:6 del 12/07/2012

Caída desde máximo

-89,63%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,20%

Cierre anterior

18,32

Rango de hoy

18,29 – 18,81

Volumen hoy

1.397.929

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,44%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 19 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
16/05/2023 153,79 154,00 147,82 149,14 -5,12% 4,02% 2.447.000
15/05/2023 151,50 159,89 147,08 157,19 +30,77% 8,46% 7.881.500
12/05/2023 120,20 120,20 120,20 120,20 +0,00% 0,00% 0
11/05/2023 120,69 121,00 113,31 120,20 -0,88% 6,37% 4.675.600
10/05/2023 131,50 134,89 121,00 121,27 -3,27% 10,56% 4.488.200
09/05/2023 126,27 128,72 124,76 125,37 -1,14% 3,14% 1.399.900
08/05/2023 131,25 131,73 126,13 126,81 -3,20% 4,27% 951.900
05/05/2023 130,13 132,45 129,20 131,00 +0,64% 2,50% 1.080.800
04/05/2023 125,38 131,06 124,88 130,17 +3,78% 4,93% 1.129.700
03/05/2023 120,45 126,97 120,01 125,43 +1,41% 5,78% 1.371.200
02/05/2023 124,64 127,14 123,61 123,69 -1,14% 2,83% 994.800
01/05/2023 122,84 126,50 122,54 125,11 +1,91% 3,22% 975.400
28/04/2023 121,41 124,29 121,23 122,77 +0,52% 2,52% 933.800
27/04/2023 122,34 123,91 121,90 122,13 -0,12% 1,64% 731.500
26/04/2023 122,53 123,45 119,52 122,28 -0,83% 3,21% 1.223.600
25/04/2023 126,75 127,55 121,71 123,30 -2,67% 4,61% 1.498.700
24/04/2023 127,17 127,89 125,75 126,68 -1,02% 1,68% 567.100
21/04/2023 126,64 128,29 125,51 127,98 +1,35% 2,20% 800.500
20/04/2023 125,15 126,52 122,27 126,27 +1,73% 3,40% 948.300
19/04/2023 125,03 126,37 122,51 124,12 -1,14% 3,09% 1.073.400
18/04/2023 125,21 126,11 121,41 125,55 +0,27% 3,75% 1.153.200
17/04/2023 122,70 126,82 122,47 125,21 +2,10% 3,55% 1.353.100
14/04/2023 123,66 124,96 120,36 122,63 -1,68% 3,72% 1.783.800
13/04/2023 121,88 131,21 121,00 124,72 -9,41% 8,38% 5.378.300
12/04/2023 139,94 140,50 136,87 137,68 -1,02% 2,59% 790.400
11/04/2023 140,64 141,69 138,35 139,10 -0,91% 2,37% 829.200
10/04/2023 139,00 141,34 136,94 140,38 -1,52% 3,17% 1.207.100
06/04/2023 138,00 143,12 137,19 142,55 +3,64% 4,30% 1.056.200
05/04/2023 138,60 139,37 136,33 137,54 -0,75% 2,19% 858.000
04/04/2023 141,62 141,94 137,56 138,58 +0,75% 3,09% 853.100